Cairo – Mubasher: The net profits of Kahira Pharmaceuticals grew by 28.14% year-on-year (YoY) to EGP 109.14 million in fiscal year 2019/2020 from EGP 85.17 million.
Sales increased to EGP 1.01 billion in the year ended 30 June, compared to EGP 962.9 million in FY18/19, according to a bourse disclosure on Sunday.
During the first nine months of FY19/20, the company achieved net profits of EGP 92.22 million, up from EGP 72.22 million in the year-ago period.
